BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31061331)

  • 1. Analysis on the Substrate Specificity of Recombinant Human Acyl-CoA Synthetase ACSL4 Variants.
    Shimbara-Matsubayashi S; Kuwata H; Tanaka N; Kato M; Hara S
    Biol Pharm Bull; 2019; 42(5):850-855. PubMed ID: 31061331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate Specificity of Human Long-Chain Acyl-CoA Synthetase ACSL6 Variants.
    Kurotaki A; Kuwata H; Hara S
    Biol Pharm Bull; 2021; 44(10):1571-1575. PubMed ID: 34602568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-chain acyl-CoA synthetase 4 participates in the formation of highly unsaturated fatty acid-containing phospholipids in murine macrophages.
    Kuwata H; Nakatani E; Shimbara-Matsubayashi S; Ishikawa F; Shibanuma M; Sasaki Y; Yoda E; Nakatani Y; Hara S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Nov; 1864(11):1606-1618. PubMed ID: 31376475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of long-chain acyl-coenzyme A synthetases in the regulation of arachidonic acid metabolism in interleukin 1β-stimulated rat fibroblasts.
    Kuwata H; Yoshimura M; Sasaki Y; Yoda E; Nakatani Y; Kudo I; Hara S
    Biochim Biophys Acta; 2014 Jan; 1841(1):44-53. PubMed ID: 24095834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of recombinant long-chain rat acyl-CoA synthetase isoforms 3 and 6: identification of a novel variant of isoform 6.
    Van Horn CG; Caviglia JM; Li LO; Wang S; Granger DA; Coleman RA
    Biochemistry; 2005 Feb; 44(5):1635-42. PubMed ID: 15683247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate's efficacy against bipolar disorder.
    Shimshoni JA; Basselin M; Li LO; Coleman RA; Rapoport SI; Modi HR
    Biochim Biophys Acta; 2011 Mar; 1811(3):163-9. PubMed ID: 21184843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism.
    Kuwata H; Hara S
    Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106363. PubMed ID: 31306767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of long-chain acyl-CoA synthetase 4 facilitates production of 5, 11-dihydroxyeicosatetraenoic acid via the cyclooxygenase-2 pathway.
    Kuwata H; Hara S
    Biochem Biophys Res Commun; 2015 Sep; 465(3):528-33. PubMed ID: 26282205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Acyl-CoA synthetase isoforms in pancreatic beta cells: Gene silencing shows participation of ACSL3 and ACSL4 in insulin secretion.
    Ansari IH; Longacre MJ; Stoker SW; Kendrick MA; O'Neill LM; Zitur LJ; Fernandez LA; Ntambi JM; MacDonald MJ
    Arch Biochem Biophys; 2017 Mar; 618():32-43. PubMed ID: 28193492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ACSL4 in the chemical-induced cell death in human proximal tubule epithelial HK-2 cells.
    Kuwata H; Tomitsuka Y; Yoda E; Hara S
    Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35103282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished acyl-CoA synthetase isoform 4 activity in INS 832/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion.
    Klett EL; Chen S; Edin ML; Li LO; Ilkayeva O; Zeldin DC; Newgard CB; Coleman RA
    J Biol Chem; 2013 Jul; 288(30):21618-29. PubMed ID: 23766516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of long-chain acyl-CoA synthetase 4 in formation of polyunsaturated lipid species in hepatic stellate cells.
    Tuohetahuntila M; Spee B; Kruitwagen HS; Wubbolts R; Brouwers JF; van de Lest CH; Molenaar MR; Houweling M; Helms JB; Vaandrager AB
    Biochim Biophys Acta; 2015 Feb; 1851(2):220-30. PubMed ID: 25500141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of p115 as a novel ACSL4 interacting protein and its role in regulating ACSL4 degradation.
    Sen P; Kan CFK; Singh AB; Rius M; Kraemer FB; Sztul E; Liu J
    J Proteomics; 2020 Oct; 229():103926. PubMed ID: 32736139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-chain acyl-CoA synthetase isoforms differ in preferences for eicosanoid species and long-chain fatty acids.
    Klett EL; Chen S; Yechoor A; Lih FB; Coleman RA
    J Lipid Res; 2017 May; 58(5):884-894. PubMed ID: 28209804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of acyl-CoA esters and acyl-CoA synthetase activity in mouse brain areas by liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Kasuya F; Masuyama T; Yamashita T; Nakamoto K; Tokuyama S; Kawakami H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 929():45-50. PubMed ID: 23644500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-chain acyl-CoA synthetase 4 modulates prostaglandin E₂ release from human arterial smooth muscle cells.
    Golej DL; Askari B; Kramer F; Barnhart S; Vivekanandan-Giri A; Pennathur S; Bornfeldt KE
    J Lipid Res; 2011 Apr; 52(4):782-93. PubMed ID: 21242590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for long-chain acyl-CoA synthetase-4 (ACSL4) in diet-induced phospholipid remodeling and obesity-associated adipocyte dysfunction.
    Killion EA; Reeves AR; El Azzouny MA; Yan QW; Surujon D; Griffin JD; Bowman TA; Wang C; Matthan NR; Klett EL; Kong D; Newman JW; Han X; Lee MJ; Coleman RA; Greenberg AS
    Mol Metab; 2018 Mar; 9():43-56. PubMed ID: 29398618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-chain acyl-CoA synthetase in fatty acid metabolism involved in liver and other diseases: an update.
    Yan S; Yang XF; Liu HL; Fu N; Ouyang Y; Qing K
    World J Gastroenterol; 2015 Mar; 21(12):3492-8. PubMed ID: 25834313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACSL4-Mediated Ferroptosis and Its Potential Role in Central Nervous System Diseases and Injuries.
    Jia B; Li J; Song Y; Luo C
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human fatty acid transport protein 2a/very long chain acyl-CoA synthetase 1 (FATP2a/Acsvl1) has a preference in mediating the channeling of exogenous n-3 fatty acids into phosphatidylinositol.
    Melton EM; Cerny RL; Watkins PA; DiRusso CC; Black PN
    J Biol Chem; 2011 Sep; 286(35):30670-30679. PubMed ID: 21768100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.